Equillium, Inc. (EQ) stock
EQNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.15−0.14 (-10.85%)
Close on Nov 16, 2026Market cap $72.92MP/E –Yield –
Equillium total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Equillium's total debt was $7.56M at Mar 31, 2023. For fiscal 2022 it was $8.95M, down 12.0% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $8.95M | -12.0% |
| FY2021 | Dec 31, 2021 | $10.18M | +2.4% |
| FY2020 | Dec 31, 2020 | $9.94M | +2.7% |
| FY2019 | Dec 31, 2019 | $9.68M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2023 | Mar 31, 2023 | $7.56M | -26.1% |
| Q4 FY2022 | Dec 31, 2022 | $8.95M | -12.0% |
| Q3 FY2022 | Sep 30, 2022 | $10.33M | +2.0% |
| Q2 FY2022 | Jun 30, 2022 | $10.28M | +2.1% |
| Q1 FY2022 | Mar 31, 2022 | $10.23M | +2.2% |
| Q4 FY2021 | Dec 31, 2021 | $10.18M | +2.4% |
| Q3 FY2021 | Sep 30, 2021 | $10.12M | +2.5% |
| Q2 FY2021 | Jun 30, 2021 | $10.07M | +2.6% |
| Q1 FY2021 | Mar 31, 2021 | $10.01M | +2.7% |
| Q4 FY2020 | Dec 31, 2020 | $9.94M | +2.7% |
| Q3 FY2020 | Sep 30, 2020 | $9.88M | +2.7% |
| Q2 FY2020 | Jun 30, 2020 | $9.81M | – |
| Q1 FY2020 | Mar 31, 2020 | $9.75M | – |
| Q4 FY2019 | Dec 31, 2019 | $9.68M | – |
| Q3 FY2019 | Sep 30, 2019 | $9.62M | – |
See a number that looks wrong?